Last edition
News about "Sandoz enters commercialization pact with Bio-Ther"
Sandoz enters commercialization pact with Bio-Thera Solutions for biosimilar bevacizumab
Sandoz, a Novartis division, announced that it has entered into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706)
Sandoz Enters Commercialization Pact With Bio-Ther | 09/09/2021 | By Darshana | 276
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members